Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T02:15:02.507Z Has data issue: false hasContentIssue false
  • English
  • Français

Novel method of intralesional cidofovir injection into laryngotracheal papillomata

Published online by Cambridge University Press:  31 January 2011

R S Sahota ,
F J Uddin ,
J AL-Shukri  and
A A Moir
R S Sahota*
Affiliation:
Department of Otorhinolaryngology, Leicester Royal Infirmary, UK
F J Uddin
Affiliation:
Department of Otorhinolaryngology, Leicester Royal Infirmary, UK
J AL-Shukri
Affiliation:
Department of Otorhinolaryngology, Leicester Royal Infirmary, UK
A A Moir
Affiliation:
Department of Otorhinolaryngology, Leicester Royal Infirmary, UK
*
Address for correspondence: Mr R S Sahota, Department of Otorhinolaryngology, Leicester Royal Infirmary, Leicester LE1 5WW, UK E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Laryngeal papillomatosis is characterised by multiple papillomata affecting the upper respiratory tract. This condition is difficult to treat due to its recurrent nature. Treatment often involves surgical debulking. A number of non-surgical treatments have been reported. Intralesional cidofovir, a cytosine nucleoside analogue with antiviral activity, has been used in an attempt to manage the condition. We present a novel technique of administering cidofovir in a case of recurrent laryngotracheal papillomata.

Keywords

LarynxPapillomaCidofovirInjection
Type
Short Communications
Information
The Journal of Laryngology & Otology , Volume 125 , Issue 4 , April 2011 , pp. 402 - 404
Copyright
Copyright © JLO (1984) Limited 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Snoeck, R, Wellens, W, Desloovere, C, Van Ranst, M, Naesens, L, De Clercq, E et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 1998;54:219–253.0.CO;2-C>CrossRefGoogle Scholar
2Pudszuhn, A, Welzel, C, Bloching, M, Neumann, K. Intralesional cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 2007;264:63–70CrossRefGoogle ScholarPubMed
3Pawlita, M, Gissmann, L. Recurrent respiratory papillomatosis: indication for HPV vaccination? [in German] Dtsch Med Wochenschr 2009;134(suppl 2):100–2CrossRefGoogle ScholarPubMed
4Shehab, N, Sweet, BV, Hogikyan, ND. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy 2005;25:977–89CrossRefGoogle ScholarPubMed
5El-Hakim, H, Waddell, AN, Crysdale, WS. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 2002;31:333–5CrossRefGoogle ScholarPubMed
6Neumann, K, Pudszuhn, A, Welzel, C, Bartel-Friedrich, S, Passmann, M. Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results [in German]. Laryngorhinootologie 2003;82:700–6Google ScholarPubMed
7Schraff, S, Derkay, CS, Burke, B, Lawson, L. American Society of Pediatric Otolaryngology members’ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004;130:1039–42CrossRefGoogle ScholarPubMed
8Bielamowicz, S, Villagomez, V, Stager, SV, Wilson, WR. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 2002;112:696–9CrossRefGoogle Scholar
9Chung, BJ, Akst, LM, Koltai, PJ. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2006;70:1911–17CrossRefGoogle Scholar
10Dikkers, FG. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir – a prospective study. Eur Arch Otorhinolaryngol 2006;263:440–3CrossRefGoogle ScholarPubMed
11Bielecki, I, Mniszek, J, Cofała, M. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol 2009;73:681–4CrossRefGoogle ScholarPubMed
12Wemer, RD, Lee, JH, Hoffman, HT, Robinson, RA, Smith, RJ. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;114:836–9CrossRefGoogle ScholarPubMed
13Kimberlin, DW. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Res 2004;63:141–51CrossRefGoogle ScholarPubMed
14Broekema, FI, Dikkers, FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2008;265:871–9CrossRefGoogle ScholarPubMed
15Lindsay, F, Bloom, D, Pransky, S, Stabley, R, Shick, P. Histologic review of cidofovir-treated recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2008;117:113–17CrossRefGoogle ScholarPubMed
16Tanna, N, Sidell, D, Joshi, AS, Bielamowicz, SA. Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective. Arch Otolaryngol Head Neck Surg 2008;134:497–500CrossRefGoogle ScholarPubMed
17 Disposable varices injector by Cook. In: http://www.cookmedical.com/esc/content/mmedia/16386_0106DVI.pdf [January 2010]Google Scholar